Dermetel is a 501-c(3) nonprofit registered in Washington, DC in the process of shifting to San Francisco, CA on a permanent basis. We provide free support materials and are re-building our 2017-founded teledermatology program.
Initially founded as a skin cancer awareness group in 2011, Dermetel has learned a tremendous amount over the past decade about how to create change effectively and is now focused exclusively on free teledermatology services. Its rare disease division has branched out into a for-profit company called Darling Therapeutics, which is developing one-time gene therapy treatments for 3 rare diseases: MSUS, IVA, and TMAU. Select resources are available on the Recommended Supplements tab.